Ian Johnson Purchases 144,844 Shares of NIOX Group Plc (LON:NIOX) Stock

NIOX Group Plc (LON:NIOXGet Free Report) insider Ian Johnson acquired 144,844 shares of the business’s stock in a transaction that occurred on Wednesday, June 25th. The shares were acquired at an average cost of GBX 8 ($0.11) per share, with a total value of £11,587.52 ($15,901.63).

Ian Johnson also recently made the following trade(s):

  • On Tuesday, May 20th, Ian Johnson sold 3,924,630 shares of NIOX Group stock. The shares were sold at an average price of GBX 65 ($0.89), for a total value of £2,551,009.50 ($3,500,767.81).

NIOX Group Trading Up 3.7%

NIOX opened at GBX 68 ($0.93) on Friday. The firm has a market cap of £27.93 billion, a price-to-earnings ratio of 2,806.24 and a beta of 0.92. NIOX Group Plc has a 52 week low of GBX 53.40 ($0.73) and a 52 week high of GBX 80 ($1.10). The business’s 50 day moving average is GBX 65.83 and its two-hundred day moving average is GBX 64.42. The company has a quick ratio of 1.94, a current ratio of 6.31 and a debt-to-equity ratio of 1.10.

NIOX Group (LON:NIOXGet Free Report) last released its earnings results on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) earnings per share (EPS) for the quarter. NIOX Group had a return on equity of 13.29% and a net margin of 28.21%. On average, research analysts predict that NIOX Group Plc will post 1.1658256 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Berenberg Bank restated a “buy” rating and set a GBX 90 ($1.24) target price on shares of NIOX Group in a report on Tuesday, April 15th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 90 ($1.24) target price on shares of NIOX Group in a research report on Tuesday, April 15th.

Get Our Latest Stock Report on NIOX Group

About NIOX Group

(Get Free Report)

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.

Recommended Stories

Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.